Table: begin end state 1 24 cytoplasmic 25 49 transmembrane 50 59 non-cytoplasmic 60 84 transmembrane 85 95 cytoplasmic 96 114 transmembrane 115 119 non-cytoplasmic 120 145 transmembrane 146 162 cytoplasmic 163 188 transmembrane 189 195 non-cytoplasmic 196 217 transmembrane 218 249 cytoplasmic 250 273 transmembrane 274 284 non-cytoplasmic 285 304 transmembrane 305 315 cytoplasmic 316 334 transmembrane 335 340 non-cytoplasmic 341 368 transmembrane 369 380 cytoplasmic 381 404 transmembrane 405 409 non-cytoplasmic 410 428 transmembrane 429 459 cytoplasmic
Input: >Pf1N1B4_180 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_180 MSDLSPVEKSGAPPEVAISMKKVAVASVIGTTVEWYDLFVFATASALVFNKVFFPDFDPL IGTLLAFGTFASAYLARIVGAALFGHFGDRLGRKSMLLVSLLTMGAATFAIGLLPNYAAI GIWAPILLLLLRVIQGLALGGEWGGAVLMAVEHAPANKRGLYGSWVQIGVPAGTMIANLA FLVIAAWLSPEDLLAWGWRIPFLASVLLIAVGLYIRLNISETPAFNKVKEAEVQVKMPLA EVFRKYWKQVVLGGIATMSTGASFNIIVAFGLTYGTQNLGFSRSVMLGVVLLSCAWCIVM LPVFGALSDRYGRKPIIVAGIVAEALVAFPMFWLMDTKELSLVIFGYLLLMTAFAANYGP IATFLAELFGTRVRYSGLSISYMLSGLLGSAATPIVTTALLAATGKGSSVAWYMIGAAFI SLVALLLLTETFKRDISEIQTAVPAADPALGKPIKSAAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server